专题:Metabolism, Diabetes, and Cancer

This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
最新文献
Redox Homeostasis in Metabolic Syndrome and Type II Diabetes: Role of Skeletal Muscle and Impact of Gold-Standard Treatments

review Full Text OpenAlex

Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

article Full Text OpenAlex

Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function

article Full Text OpenAlex

The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness

review Full Text OpenAlex

Tuning insulin receptor signaling using de novo-designed agonists

article Full Text OpenAlex

Calcium-sensing receptor: a potential target for liver health and diseases

review Full Text OpenAlex

Exploiting metabolic cell death for cancer therapy

review Full Text OpenAlex

Inhibition of DHHC9-mediated CD36 palmitoylation lessens high-fat diet (HFD)-induced impairment of pubertal mammary gland development through the JNK-ERK pathway

article Full Text OpenAlex

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes

article Full Text OpenAlex

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

article Full Text OpenAlex

近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

article Full Text OpenAlex 1982 FWCI665.69359911

The hallmarks of cancer metabolism: Still emerging

review Full Text OpenAlex 1210 FWCI166.54673195

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

article Full Text OpenAlex 1111 FWCI958.74031292

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

review Full Text OpenAlex 886 FWCI178.40092953

New insights into activation and function of the AMPK

review Full Text OpenAlex 793 FWCI96.85542733

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

article Full Text OpenAlex 777 FWCI260.35717317

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes

article Full Text OpenAlex 756 FWCI158.60200701

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

article Full Text OpenAlex 727 FWCI151.44069461

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 707 FWCI88.11751711

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 673 FWCI125.32752515